Person profile
Address
San Diego, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Adaptimmune Therapeutics PLC
1 Jul 24
4
Stoke Therapeutics, Inc.
7 Jun 24
4
Black Diamond Therapeutics, Inc.
6 Jun 24
4
Adaptimmune Therapeutics PLC
10 Jul 23
4
Adaptimmune Therapeutics PLC
5 Jul 23
4
Adaptimmune Therapeutics PLC
3 Jul 23
4
Stoke Therapeutics, Inc.
15 Jun 23
4
Adaptimmune Therapeutics PLC
1 Jun 23
3
Adaptimmune Therapeutics PLC
1 Jun 23
4
TCR2 THERAPEUTICS INC.
1 Jun 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Jul 24 | ADAP Adaptimmune Therapeutics | Option to purchase Ordinary Shares Ordinary Shares | Grant | Acquire A | No | No | 0.16 | 1,121,604 | 179.46 k | 1,121,604 |
6 Jun 24 | BDTX Black Diamond Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 4.65 | 30,550 | 142.06 k | 30,550 |
5 Jun 24 | STOK Stoke Therapeutics | Director Stock Option Common Stock | Grant | Acquire A | No | No | 16.41 | 7,639 | 125.36 k | 7,639 |
3 Jul 23 | ADAP Adaptimmune Therapeutics | Option to purchase Ordinary Shares Ordinary Shares | Grant | Acquire A | No | No | 0.16 | 981,463 | 157.03 k | 981,463 |
13 Jun 23 | STOK Stoke Therapeutics | Director Stock Option Common Stock | Grant | Acquire A | No | No | 12.46 | 19,441 | 242.23 k | 19,441 |